This year’s industry event: I Private Healthcare Forum in Poland is behind us! On 10 September 2020, we met among key providers, manufacturers of medical equipment, IT solutions, pharmaceutical companies as well as investors and media partners to discuss the situation in the sector and forecasts for the next year. The event was full of…
The European Commission (EC) announced at the end of last week that it had signed a contract to purchase 400 million doses of COVID-19 vaccine. The contract was signed with AstraZeneca. The value of the contract has not been disclosed. It is only known that the EC paid an advance of EUR 336m. Vaccine purchase…
Will there be a global pool of exclusive rights for tests, drugs and vaccines for coronavirus? As Dr Aleksandra Solyga-Zurek, European and Polish patent attorney from Patpol, says in an interview with PMR, the idea has already been supported by WHO. It is worth noting that without this solution, pharmaceutical companies have recently come under…
Dirk Kreder was appointed president of the Polish biotechnology company Mabion. New president of Mabion Dirk Kreder has extensive experience in managing small and large pharmaceutical companies in Europe and the United States. He has contributed to the development and registration of biosimilar and generic drugs on markets in several dozen countries. He has 10…
Pratia, a member of the Neuca Group, acquired 100% of shares in Examen, a company specialising in oncology and haematology research. The acquisition is a consequence of the implementation of the Neuca Group’s strategy in the area of clinical oncology research with a special focus on haematooncology. Another takeover The connection to Examen is another…
Google is today not only a huge weapon for the promotion of medicines and pharmaceutical companies, but also a pharmaceutical company. Recently, the company has been taking more and more initiatives in the life sciences sector. Diversification of Google’s activities also included pharmacy In 2015 Larry Page and Sergey Brin, co-founders of the giant, decided…
Polfa Tarchomin, a Polish state-owned pharmaceutical producer, is planning an investment program, informs Puls Biznesu. It wants to expand its product portfolio and develop contact manufacturing. It intends to obtain funds for the development, among others, from the sale of land. New generic medicines Currently, half of Polfa Tarchomin’s revenue comes from antibiotics, and another…
Significant legal changes are underway in the market of products notified to the Chief Sanitary Inspector (GIS), including the segment of dietary supplements. The draft law that will introduce them will probably come out next year, Mateusz Pazdan, President of SFD, a leading manufacturer of nutritional supplements for sportsmen and sportswomen, and Business Centre Club…
According to information in the press, there are more than 100 medicines missing in Poland. Everything seems to indicate that the problem will get worse and that in the near future the prices of some medicines will go up. China closes factories producing raw materials for pharmaceuticals The Chinese authorities have recently decided to close…
The telemedicine company MedApp is rebuilding its management board and strengthening the team of specialists. The aim is to develop the company on the Polish and foreign markets. Rafal Ligezinski as Vice President The company informed in a press release that on 14th May Rafał Ligeziński was appointed to the position of Vice President of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.